Drug recall D-1048-2017
Product
Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25).
Reason for recall
Lack of Sterility Assurance
Lots and codes
a.) one vial Lot: 74393EV Exp. 05/01/2018 Lot: 75157EV Exp. 06/01/2018 Lot: 75367EV, Exp. 06/01/2018 b.) 25 vial carton Lot: 75158EV; Exp. 06/01/2018
Recall details
- Recalling firm
- Hospira a Pfizer Company, Rocky Mount, NC
- Quantity
- 15,034,600 10 mL multiple dose use vials
- Distribution
- U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore
- Type
- Voluntary: Firm initiated
- Recall initiated
- June 15, 2017
- Terminated
- July 20, 2020
Related products
- Quelicin – drug information
- NDC 0409-6629 Quelicin · Succinylcholine Chloride 20 mg/mL · Hospira, Inc.